Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Piper Sandler

Pinterest To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Palantir Stock Deserves Valuation Premium: Analyst Says Growth + Margin Equals 'Category Of One'

Palantir Stock Deserves Valuation Premium: Analyst Says Growth + Margin Equals 'Category Of One'

Palantir Technologies (NASDAQ:PLTR) analysts highlight the company's accelerating growth after it reported second-quarter financial results and provided guidance ahead of estimates.

Palantir Technologies To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Tuesday

Palantir Technologies To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Tesla Gains on Elon Musk's New Pay Package. Is TSLA Stock a Buy?

Tesla has awarded 96 million company shares to Elon Musk as part of an interim pay package. Here’s how you should play TSLA shares following the announcement.

Palantir Stock Is Trending Today: What's Going On?

Palantir Technologies Inc (NASDAQ:PLTR) shares are trading higher Monday ahead of earnings scheduled after the bell. Here’s what you need to know before the report.

From AI To Emerging Markets: How 6 Pros Would Allocate $10K In Today's Market

Amid record-high markets, six Wall Street strategists shared where they would deploy $10,000 right now, identifying areas ranging from artificial intelligence to emerging markets, according to Business Insider.

Alnylam's Amvuttra Makes Powerful Entrance, Eyes First-Line Dominance

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) reported upbeat second-quarter earnings and 2025 guidance on Thursday.

inkl

Read news from The Economist, FT, and more,
with one subscription

Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday

Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Marjorie Taylor Greene Piles Into PepsiCo and Palantir Stocks, Treasury Bills in Latest Trades

Marjorie Taylor Greene Piles Into PepsiCo and Palantir Stocks, Treasury Bills in Latest Trades

Congress member Marjorie Taylor Greene purchased PepsiCo and Palantir stocks, with each trade valued between $1,000 and $15,000. She also invested up to $750,000 in T-bills across three trades.

International Business Times UK

Meta To Rally More Than 56%? Here Are 10 Top Analyst Forecasts For Thursday

Meta To Rally More Than 56%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

QUALCOMM Stock Is Trading Lower Thursday: What's Going On?

QUALCOMM Stock Is Trading Lower Thursday: What's Going On?

Qualcomm Incorporated (NASDAQ:QCOM) shares are trading lower Thursday after the company reported third quarter financial results.

Green Apron, Red Flag? Starbucks Analysts Wonder About $500 Million Investment As Sales Slump

Green Apron, Red Flag? Starbucks Analysts Wonder About $500 Million Investment As Sales Slump

Shares of Starbucks Corp (NASDAQ:SBUX) were under pressure in early trading on Wednesday, after the company Tuesday reported downbeat fiscal third-quarter earnings.

UnitedHealth Prognosis Mixed: Analysts Trim Targets But Keep Faith After Q2 Miss

UnitedHealth Prognosis Mixed: Analysts Trim Targets But Keep Faith After Q2 Miss

Shares of UnitedHealth Group Inc (NYSE:UNH) remained volatile in early trading on Wednesday, after a downbeat second-quarter report.

Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong

Generic Revlimid Fades, But Teva's Broader Generics Outlook Remains Strong

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will release its second-quarter 2025 financial results tomorrow, July 30.

Get all your
news in one place.

100's of premium titles.
One news app.

Cadence Design Systems Delivers Beat-And-Raise Quarter Despite US Export Bans

Shares of Cadence Design Systems Inc (NASDAQ:CDNS) rallied in early trading on Tuesday, after the company Monday reported upbeat second-quarter earnings.

Lululemon Athletica Is 'Over-Investing In Innovation,' Analyst Cuts Price Target

There could be further risk to Lululemon Athletica Inc's (NASDAQ:LULU) estimates, given its continued product execution issues and sale section growth, according to Piper Sandler.

Uber To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Halliburton Has Rug Pulled From Under It, Analyst Blames Tariffs And OPEC

Tariffs introduced on the so-called “Liberation Day” and OPEC+ production hikes have "pulled the rug out" from under Halliburton Co (NSE: HAL), according to Piper Sandler.

Get all your
news in one place.

100's of premium titles.
One news app.

Palantir Stock Offers ‘One of a Kind Growth.’ Should You Buy PLTR Here?

Palantir stock inches up on Piper Sandler’s bullish note in favor of the big data analytics firm. Brent Bracelin says valuation alone shouldn’t define PLTR shares.

Trump’s trade deals are illegal, Piper Sandler warns, predicting a Supreme Court smackdown by June 2026

The investment bank thinks a 9–0 ruling against Trump is likely. That doesn’t mean the tariffs will just go away.

Alphabet To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Amazon To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

CrowdStrike Bulls Beware: This Trade May Be Getting Crowded

CrowdStrike remains a cybersecurity leader, but mixed analyst ratings and technical signals point to a likely correction after a strong 12-month run

Netflix To Rally More Than 11%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Why Citigroup Is Still The Best Value Bet In Large-Cap Banking

Citigroup (NYSE:C) has kicked off earnings season with strong second-quarter 2025 results, prompting several Wall Street analysts to reiterate positive ratings and raise price forecasts for the banking giant.

1 … 3 4 5 6

People

197,817 stories

Marjorie Taylor

James Schneider

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

the Supreme Court

Bank of America

Amazon.com Inc.

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Emerging Markets

Places

389,016 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play